ALPROSTADIL by Hikma is clinical pharmacology alprostadil (prostaglandin e 1 ) is one of a family of naturally occurring acidic lipids with various pharmacologic effects. First approved in 1998.
Drug data last refreshed 17h ago
CLINICAL PHARMACOLOGY Alprostadil (prostaglandin E 1 ) is one of a family of naturally occurring acidic lipids with various pharmacologic effects. Vasodilation, inhibition of platelet aggregation, and stimulation of intestinal and uterine smooth muscle are among the most notable of these effects.…
Worked on ALPROSTADIL at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Alprostadil in Maculopathy Study (AIMS)
Topical Alprostadil for Female Sexual Arousal Disorder
Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Hikma is hiring 3 roles related to this product